-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-selection-harms-systematic-reviews.pdf
February 01, 2018 - Serious or
Common and Bothersome Harms (II)
• Reviews should give priority to final (mortality,
morbidity … considered lower priority than patient-centered health outcomes such as mortality, outcomes related to morbidity
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
March 01, 2016 - care, adherence and retention in care,
sustain a below detectable plasma viral load, and decrease morbidity … Examples of person-level
outcomes include clinical outcomes such as mortality and morbidity, mental
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
July 06, 2015 - failure: results from the CHARM
(Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity … failure: The CHARM
programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity … and location of lesion, presence and pattern of
symptoms), dose of the ACE inhibitor or ARB used, co-morbidities … BACKGROUND: Heart failure with preserved ejection fraction is associated with substantial morbidity and … and location of lesion, presence and pattern of
symptoms), dose of the ACE inhibitor or ARB used, co-morbidities
-
effectivehealthcare.ahrq.gov/products/hip-fracture-pain/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-appendix-3.xlsx
June 24, 2022 - characteristics, primarily the patient population studied (age, sex, severity of disease and presence of co-morbidities … actually experienced by patients, such as quality of life, functional status, duration of disability, morbidity … actually experienced by patients, such as quality of life, functional status, duration of disability, morbidity … depends on primarily the patient population studied (age, sex, severity of disease and presence of co-morbidities
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda-krishnan.pdf
August 27, 2012 - Use of Analytic Hierarchy Process to elicit stakeholder preferences for prioritizing research
Slide 1
Use of Analytic Hierarchy Process to elicit stakeholder preferences for prioritizing
research
August 27, 2012
Jerry A. Krishnan, MD, PhD (jakris@uic.edu)
Professor of Medicine and Public Health
Associate V…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
April 28, 2010 - misuse followed by a behavioral counseling intervention, with or
without referral, leads to reduced morbidity … interventions, with or without referral, compare with one another and with usual care for
reducing morbidity … misuse followed
by a behavioral counseling intervention, with
or without referral, leads to reduced morbidity … interventions, with or without referral, compare
with one another and with usual care for
reducing morbidity … Studies were generally not designed to assess the impact
of the interventions on morbidity and mortality
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
January 31, 2013 - For all patients with
PAD, both symptomatic and asymptomatic, reducing the risk of cardiovascular morbidity … Reducing Cardiovascular Morbidity and Mortality in All Patients With PAD
The goal of medical therapy … is to reduce the risk of future cardiovascular morbidity and
mortality in patients with high ischemic … use of local anesthesia rather than general anesthesia, short recovery times, and
reduced short-term morbidity … Progression of peripheral arterial disease
predicts cardiovascular disease morbidity and mortality.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - number one attributable risk factor for death throughout the world,
hypertension results in substantial morbidity … Despite the high morbidity and mortality attributable to hypertension, control remains
suboptimal. … pressure is the number one attributable risk factor for death throughout the
world.2 Substantial excess morbidity … Despite the high morbidity and mortality attributable to hypertension, control remains
suboptimal. … (-1.0 to 3.5%)
-
High
Mortality and major
CV events 1663 1659 - - Moderate Critical
Morbidity
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bereaved-persons-research-executive-summ.pdf
March 01, 2025 - ICD-11 for Mortality and Morbidity
Statistics. 2018. https://icd.who.int/dev11/l-
m/en#/http%3a%2f%2fid.who.int
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
July 01, 2012 - would not in itself provide any direct
evidence of the value of SNP-based test panels in reducing
morbidity … evidence that surveillance, diagnostic, and treatment
strategies in themselves lead to reductions in morbidity
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-survivor-care-transition_research-protocol.pdf
March 27, 2013 - patient outcomes related to the
survivorship care model
• Intermediate patient health outcomes
• Morbidity … interventions
Comparator • Type of comparator
Outcomes measured • Intermediate patient health outcomes
• Morbidity
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
January 01, 2016 - 105/144) NR NA 145 11 NA 105 39 NA
Gamberini, 2019 3 SGA Laryngeal Tube 33 ETI Orotracheal Tube 147 Morbidity … NA NA 0 vs. 1.4% (1/73) NR NA NA NA NA NA NA NA
Hansen, 2020 3 SGA I-Gel, King LT 6 ETI Direct 21 Morbidity … 2.8% to 6.4%), p<0.001 NR NA 69 959 NA 21 975 NA
Jabre, 2018
Malinverni, 2019 2 BVM NR 54 ETI NR 58 Morbidity … and 6-12 0% (0) vs. 1% (1) vs. 0% (0) NR NA NA NA NA NA NA NA
Prekker, 2016 4 ETI NR 219 NA NA NA Morbidity … ; difference 0.1% (-1.3 to 1.4), p=0.90 NR NA 5 455 NA 4 396 NA
Wang, 2018 3 SGA LT 460 ETI NR 400 Morbidity
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
June 04, 2010 - including:
1) Gender;
2) Age group (< 6 years, 6–12 years, 13–18 years, 19–24 years);
3) Race;
4) Co-morbidities … antipsychotics in
different subpopulations (KQ4), including but not limited to age, gender, race, co-morbidity … characteristics (diagnosis and age at diagnosis, age, sex, race,
weight, height, body mass index, co-morbidities
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-family-engagement-protocol.pdf
December 31, 2019 - hospital, emergency room, and primary care services), and clinical outcomes (e.g., disease-
specific morbidity … Health system level changes (e.g. new population
health programs)
• Patient outcomes
o Chronic disease morbidity
-
effectivehealthcare.ahrq.gov/products/c-diff-infections/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-254-rural-telehealth-executive-summary.pdf
December 01, 2022 - disparities for people living in rural areas.1
Rural populations experience higher mortality2-5 and morbidity
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/field-triage-glascow_executive.pdf
January 01, 2017 - is the predictive utility of the tGCS
compared with the mGCS for predicting in-hospital
mortality, morbidity … effectiveness of the
tGCS compared with the mGCS on clinical outcomes
(e.g., in-hospital mortality, morbidity … For Key Question 1, we included measures of predictive
utility for in-hospital mortality, morbidity,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
February 01, 2024 - nonprescription, is extremely common for
numerous physical and mental health conditions and can have benefits on morbidity … multiple aspects of patient safety and
quality of care, including by reducing drug burden, ADEs, and morbidity … , is extremely common
for numerous physical and mental health conditions and can have benefits on
morbidity … multiple aspects of patient safety and quality of care, including
by reducing drug burden, ADEs, and morbidity
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_disposition-comments.pdf
January 01, 2011 - tests will result
in any significant improvement in intermediate outcomes,
safety, quality of life, morbidity … Among the
confounders: co-morbidities; parenteral iron
administration; dialysis for many; administration